Then, we demonstrated that 51.8, 37.3, and 54.2 % of high-grade gliomas in our collection (including IDH1-mutated tumors) were promoter methylated as determined by HRM, MSP, and PSQ, respectively, indicating HRM and PSQ provided comparable results. Here, IDH1 is linked to central nervous system cancer.